| Ident. | Authors (with country if any) | Title |
|---|
| 001528 (2012) |
Olena Babenko [Canada] ; Igor Kovalchuk [Canada] ; Gerlinde A. Metz [Canada] | Epigenetic programming of neurodegenerative diseases by an adverse environment |
| 001936 (2011) |
Moonhee Lee [Canada] ; Nattinee Jantaratnotai [Canada] ; Edith Mcgeer [Canada] ; James G. Mclarnon [Canada] ; Patrick L. Mcgeer [Canada] | Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels |
| 002370 (2008) |
Chinar Dara [Canada] ; Laura Monetta [Canada] ; Marc D. Pell [Canada] | Vocal emotion processing in Parkinson's disease : Reduced sensitivity to negative emotions |
| 002402 (2008) |
Silke Paulmann [Allemagne, Canada] ; Marc D. Pell [Canada] ; Sonja A. Kotz [Allemagne] | Functional contributions of the basal ganglia to emotional prosody : Evidence from ERPs |
| 002413 (2008) |
Alison Fenney [Canada] ; Mandar S. Jog [Canada] ; Christian Duval [Canada] | Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology |
| 002639 (2007) |
Brian N. Mathur [États-Unis] ; M. Diana Neely [États-Unis] ; Melanie Dyllick-Brenzinger [Canada] ; Anurag Tandon [Canada] ; Ariel Y. Deutch [États-Unis] | Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration |
| 002644 (2007) |
Jennifer E. Tobin [États-Unis] ; JING CUI [États-Unis] ; Jemma B. Wilk [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Jason M. Laramie [États-Unis] ; Ann C. Mckee [États-Unis] ; Mark Guttman [Canada] ; Samer Karamohamed [États-Unis] ; Anita L. Destefano [États-Unis] ; Richard H. Myers [États-Unis] | Sepiapterin reductase expression is increased in Parkinson's disease brain tissue |
| 002707 (2006) |
Christina R. Zamzow [Canada] ; Ratna Bose ; Fiona E. Parkinson | The effect of acidosis on adenosine release from cultured rat forebrain neurons. |
| 002750 (2006) |
Christian Duval [Canada] ; Abbas F. Sadikot ; Michel Panisset | Bradykinesia in patients with essential tremor. |
| 002915 (2006) |
Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada] | Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease |
| 002933 (2006) |
Tony Y. Wang [Canada] ; Arindom Sen [Canada] ; Leo A. Behie [Canada] ; Michael S. Kallos [Canada] | Dynamic behavior of cells within neurospheres in expanding populations of neural precursors |
| 002941 (2006) |
Christian Duual [Canada] ; Abbas F. Sadikot [Canada] ; Michel Panisset [Canada] | Bradykinesia in patients with essential tremor |
| 002952 (2005) |
Kelly K. Meissner [Canada] ; David L. Kirkham ; Laurie C. Doering | Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's. |
| 002966 (2005) |
Fiona E. Parkinson [Canada] ; Cindy Hacking | Pericyte abundance affects sucrose permeability in cultures of rat brain microvascular endothelial cells. |
| 002B16 (2005) |
Sarah A. Baker [États-Unis] ; Lianne E. Stanford [Canada] ; Richard E. Brown [Canada] ; Theo Hagg [États-Unis] | Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice |
| 002B18 (2005) |
Wiplove Lamba [Canada] ; Wendy Prichett [Canada] ; David Munoz [Canada] ; David S. Park [Canada] ; John M. Woulfe [Canada] | MPTP induces intranuclear rodlet formation in midbrain dopaminergic neurons |
| 002B77 (2004) |
Maïa Miguelez [Canada] ; Amanda C. Kentner ; Kim Deslauriers ; Matthew Parkinson ; George Fouriezos ; Catherine Bielajew | Interhemispheric involvement of the anterior cortical nuclei of the amygdala in rewarding brain stimulation. |
| 002D09 (2004) |
Gerlinde A. Metz [Canada] ; Dionne M. Piecharka [Canada] ; Jeffrey A. Kleim [Canada] ; Ian Q. Whishaw [Canada] | Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease |
| 002D53 (2003) |
Fiona E. Parkinson [Canada] ; Jessica Friesen ; Ljiljana Krizanac-Bengez ; Damir Janigro | Use of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain. |
| 002F31 (2003) |
LI LIU [Canada] ; Shu S. Hsu [Canada] ; Suneil K. Kalia [Canada] ; Andres M. Lozano [Canada] | Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP |
| 003196 (2001) |
Vemuganti L. Raghavendra Rao [États-Unis] ; Aclan Dogan [États-Unis] ; Kathryn G. Todd [Canada] ; Kellie K. Bowen [États-Unis] ; Robert J. Dempsey [États-Unis] | Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats |
| 003265 (2001) |
Christopher J. D. Sinclair [Canada] ; Ljiljana Krizanac-Bengez [États-Unis] ; Kathë A. Stanness [États-Unis] ; Damir Janigro [États-Unis] ; Fiona E. Parkinson [Canada] | Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole |
| 003428 (2000) |
Philip M. Wall [Canada] ; Claude Messier [Canada] | U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice |
| 003454 (2000) |
Dom Miceli [Canada] ; Jacques Repérant [Canada] ; Jean-Paul Rio [France] ; Jean Désilets [Canada] ; Monique Médina [France] | Quantitative immunogold evidence that glutamate is a neurotransmitter in afferent synaptic terminals within the isthmo-optic nucleus of the pigeon centrifugal visual system |
| 003479 (2000) |
Lyne Lévesque [Canada, États-Unis] ; Craig A. Mizzen [États-Unis] ; Donald R. Mclachlan [Canada] ; Paul E. Fraser [Canada] | Ligand specific effects on aluminum incorporation and toxicity in neurons and astrocytes |
| 003794 (1999) |
J. Gauthier [Canada] ; M. Parent [Canada] ; M. Levesque [Canada] ; A. Parent [Canada] | The axonal arborization of single nigrostriatal neurons in rats |
| 003824 (1999) |
T. Inoue [Canada, Japon] ; J. Tsui [Canada] ; N. Wong [Canada] ; SHIN YI WONG [Canada] ; F. Suzuki [Japon] ; YIN NAM KWOK [Canada] | Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment |
| 003878 (1998) |
Douglas G. Walker [Canada] ; Thomas G. Beach [Canada, États-Unis] ; Ren Xu [États-Unis] ; Jack Lile [États-Unis] ; Klaus D. Beck [États-Unis] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease |
| 003976 (1998) |
Douglas G. Walker [Canada, États-Unis] ; Kazuhiro Terai [Canada, Japon] ; Akinori Matsuo [Canada, Japon] ; Thomas G. Beach [Canada, États-Unis] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases |
| 003B54 (1997) |
Mindy F. Levin [Canada] ; Marius Dimov [Canada] | Spatial zones for muscle coactivation and the control of postural stability |
| 003B60 (1997) |
Ivar Mendez [Canada] ; Murray Hong [Canada] | Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase |
| 003B86 (1997) |
Edith Sánchez ; Jean-Louis Charli [Mexique] ; Claudia Morales ; Gabriel Corkidi [Mexique] ; Nabil G. Seidah [Canada] ; Patricia Joseph-Bravo ; Rosa Maria Uribe | Expression of the proprotein convertases PC1 and PC2 mRNAs in thyrotropin releasing hormone neurons of the rat paraventricular nucleus of hypothalamus |
| 003C10 (1997) |
Patrick L. Mcgeer [Canada] ; Douglas G. Walker [Canada] ; Robert E. Pitas [États-Unis] ; Robert W. Mahley [États-Unis] ; Edith G. Mcgeer [Canada] | Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro |
| 003C73 (1997) |
R. Kakkar [Canada] ; R. V. S. Raju [Canada] ; A. H. Rajput [Canada] ; R. K. Sharma [Canada] | Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme |
| 003E10 (1996) |
David J. Martens [Canada] ; Ian Q. Whishaw [Canada] ; Elena I. Miklyaeva [Canada] ; Sergio M. Pellis [Canada] | Spatio-temporal impairments in limb and body movements during righting in an hemiparkinsonian rat analogue: relevance to axial apraxia in humans |
| 003E25 (1996) |
Claudia Schwab [Canada] ; John C. Steele ; Patrick L. Mcgeer [Canada] | Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins |
| 003E26 (1996) |
Yulin Liu [Canada, États-Unis] ; Karina F. Meiri [États-Unis] ; Max S. Cynader [Canada] ; Qiang Gu [Canada] | Nerve growth factor induced modification of presynaptic elements in adult visual cortex in vivo |
| 003E69 (1996) |
R. Grondin [Canada] ; M. Goulet [Canada] ; T. Di Paolo [Canada] ; P. J. Bédard [Canada] | Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates |
| 003E98 (1996) |
M. Goulet [Canada] ; R. Grondin ; P. J. Blanchet ; P. J. Bedard ; T. Di Paolo [Canada] | Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode to not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys |
| 003F98 (1995) |
Kathy Steece-Collier [États-Unis] ; David M. Yurek [États-Unis] ; Timothy J. Collier [États-Unis] ; Fred S. Junn [Canada] ; John R. Sladek Jr. [États-Unis] | The detrimental effect of levodopa on behavioral efficacy of fetal dopamine neuron grafts in rats is reversible following prolonged withdrawal of chronic dosing |
| 004003 (1995) |
Weiya Ma [Canada] ; A. Ribeiro-Da-Silva [Canada] | Substance P- and GABA-like immunoreactivities are co-localized in axonal varicosities in the superficial laminae of cat but not rat spinal cord |
| 004027 (1995) |
F. Calon [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; J. C. Martel [Canada] ; M. F. Piercey [États-Unis] ; P. J. Be Dard [Canada] ; T. Di Paolo [Canada] | Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex |
| 004035 (1995) |
Elena I. Miklyaeva [Canada] ; David J. Martens [Canada] ; Ian Q. Whishaw [Canada] | Impairments and compensatory adjustments in spontaneous movement after unilateral dopamine depletion in rats |
| 004050 (1995) |
Suzanne M. Delaney [Canada] ; Jonathan D. Geiger [Canada] | Enhancement of NMDA-induced increases in levels of endogenous adenosine by adenosine deaminase and adenosine transport inhibition in rat striatum |
| 004206 (1994) |
Hyman M. Schipper [Canada] ; G. Clarissa Desjardins [Canada] ; Alain Beaudet [Canada] ; James R. Brawer [Canada] | The 21-aminosteroid antioxidant, U74389F, prevents estradiol-induced depletion of hypothalamic β-endorphin in adult female rats |
| 004213 (1994) |
I. Tooyama [Canada, Japon] ; E. G. Mcgeer [Canada] ; T. Kawamata [Canada, Japon] ; H. Kimura [Japon] ; P. L. Mcgeer [Canada] | Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrast with loss in Parkinson's disease |
| 004232 (1994) |
K. Shannak ; A. Rajput [Canada] ; B. Rozdilsky [Canada] ; S. Kish ; J. Gilbert [Canada] ; O. Hornykiewicz | Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects |
| 004260 (1994) |
Jean-Jacques Soghomonian [Canada] | Differential regulation of glutamate decar☐ylase and preproenkephalin mRNA levels in the rat striatum |
| 004272 (1994) |
Ali Charara [Canada] ; Andre Parent [Canada] | Brainstem dopaminergic, cholinergic and serotoninergic afferents to the pallidum in the squirrel monkey |
| 004276 (1994) |
Paul G. Noble [Canada] ; Jack P. Antel [Canada] ; Voon Wee Yong [Canada] | Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes |
| 004302 (1994) |
P. J. Blanchet [Canada] ; R. Boucher [Canada] ; P. J. Bedard | Excitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys |
